Stifel Financial’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Stifel Financial’s Portfolio FLXN Stock Details FLXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-11,490	Closed	-$70K	–	3531
2021 Q3	$70K	Hold	11,490	–	–	﹤0.01%	3262
2021 Q2	$95K	Buy	11,490 +240	+2%	+$2.04K	﹤0.01%	3242
2021 Q1	$101K	Buy	+11,250	New	+$129K	﹤0.01%	3122
2020 Q3	–	Sell	-10,000	Closed	-$132K	–	3011
2020 Q2	$132K	Buy	+10,000	New	+$104K	﹤0.01%	2676
2018 Q4	–	Sell	-11,550	Closed	-$212K	–	2853
2018 Q3	$212K	Sell	11,550 -1,700	-13%	-$39.1K	﹤0.01%	2558
2018 Q2	$342K	Buy	13,250 +100	+0.8%	+$2.6K	﹤0.01%	2217
2018 Q1	$293K	Buy	+13,150	New	+$321K	﹤0.01%	2269

Stifel Financial's FLXN Position: Q4 2021 in Review

Stifel Financial sold out of Flexion Therapeutics, Inc. (FLXN) in Q4 2021, closing a stake of 11,490 shares — an estimated $70K sold.

Stifel Financial first reported a position in FLXN in Q1 2018 and held it in 7 quarters. The position peaked at $342K in Q2 2018. 1 fund tracked by Wall St. Rank holds FLXN as of Q4 2021.

Stifel Financial reported no remaining Flexion Therapeutics, Inc. position as of Q4 2021 after selling out during the quarter.
Stifel Financial sold 11,490 Flexion Therapeutics, Inc. shares in Q4 2021, an estimated $70K.
Stifel Financial first reported a position in Flexion Therapeutics, Inc. in Q1 2018 and held it in 7 quarters.
Stifel Financial's Flexion Therapeutics, Inc. position peaked at $342K in Q2 2018.
1 fund tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q4 2021.

Based on Stifel Financial's 13F filing for Q4 2021, filed 14 Feb 2022.